Lantheus Holdings, Inc. (LNTH) Financials

LNTH Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 2.4 billion 1.1 billion
March 31, 2026 2.3 billion 1.1 billion
Dec. 31, 2025 2.2 billion 1.1 billion
Sept. 30, 2025 2.3 billion 1.2 billion

LNTH Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 211.8 million 36.0 million
March 31, 2026 121.9 million 16.0 million
Dec. 31, 2025 81.4 million 17.5 million
Sept. 30, 2025 94.7 million 24.5 million

LNTH Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 193.4 million
March 31, 2026 118.4 million
Dec. 31, 2025 54.1 million
Sept. 30, 2025 27.8 million

LNTH Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 593.3 million 570.4 million 53.9 million
March 31, 2026 498.6 million 569.6 million 55.3 million
Dec. 31, 2025 359.1 million 617.4 million 51.3 million
Sept. 30, 2025 382.0 million 566.4 million 52.2 million

LNTH Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 67.5 million
March 31, 2026 65.8 million
Dec. 31, 2025 66.3 million
Sept. 30, 2025 67.7 million

LNTH Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 5.6 million 38.2 million 103.4 million 82.8 million
March 31, 2026 3.2 million 39.4 million 110.2 million 52.7 million
Dec. 31, 2025 8.8 million 47.5 million 116.2 million 46.3 million
Sept. 30, 2025 10.6 million 48.0 million 130.7 million 48.8 million

LNTH Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 388.2 million 146.3 million
March 31, 2026 377.3 million 146.4 million
Dec. 31, 2025 406.8 million 165.9 million
Sept. 30, 2025 384.0 million 161.6 million

LNTH Revenue by Segment

Graph available only for paid members. Upgrade to see it.

LNTH

Price: $100.02

52 week price:
49.67
111.86

Payout Ratio Range:
-36.85%
-0.62%

Earnings Per Share: 4.18 USD

P/E Ratio: 24.16

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 24390

Ebitda: 17.5 million

Market Capitalization: 6.5 billion

Links: